Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Baxter Healthcare Corporation
WARNING LETTER
•Baxter Healthcare Corporation•December 14, 2009

Baxter Healthcare Corporation – FDA Warning Letter, Dec 14, 2009

Record Details

The FDA issued a Warning Letter to Baxter Healthcare Corporation, Renal Division, following a November-December 2009 inspection, citing significant deviations from medical device regulations. The firm's HomeChoice peritoneal dialysis systems, MiniCaps, and transfer sets were deemed misbranded due to failures in Medical Device Reporting (MDR) under 21 CFR Part 803. Violations included inadequate internal systems for identifying and evaluating MDR events (21 CFR 803.17), failure to submit timely reports for deaths/serious injuries (21 CFR 803.50(a)(1)) and device malfunctions likely to cause serious harm (21 CFR 803.50(a)(2)). Additionally, the inspection revealed Quality System regulation deficiencies (21 CFR Part 820), such as inadequate procedures for corrective and preventive actions (CAPA) regarding nonconforming products and verifying CAPA effectiveness (21 CFR 820.100(a)(3), (a)(4)). Complaint handling procedures were found to be inconsistent (21 CFR 820.198(a)(1)), and procedures for controlling manufacturing materials to prevent adverse effects on device quality were lacking (21 CFR 820.70(h)). The firm's responses to the FDA 483 observations were largely inadequate. Baxter must promptly correct these violations within 15 working days, providing a detailed plan and documentation. Non-compliance may result in regulatory actions, including seizure, injunction, civil penalties, and impact product approvals and international trade.

Company
Baxter Healthcare Corporation
Inspection date
December 14, 2009
Product type
Devices
Office
Chicago District Office
People
  • Scott J. Macintire
  • Lorelei Jarrell
View Company Profile

ID · 7e939321-9382-4785-a392-a02bf6550265

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 352(t)(2)21 U.S.C. 360i21 CFR 80321 CFR 803.1721 CFR 803.321 CFR 803.50(a)(1)21 CFR 803.50(a)(2)21 CFR 82021 CFR 820.100(a)(3)

Full citation text and observation details available on the Dashboard.

Other documents for Baxter Healthcare Corporation
  • WARNING_LETTER - 2010-08-26August 26, 2010

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Baxter Healthcare Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.